Try Ageless vs Direct Meds
Two GLP-1 desks, one scoreboard. We put Try Ageless and Direct Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
Try Ageless
FDA warning letter, September 2025 — issued to Lovely Meds, Inc. dba Lovely Meds. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. See the FDA's warning letter database.
Direct Meds
FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.
The verdict
Direct Meds takes this head-to-head.
Direct Meds scores 82 to 58 on our six-factor Brief Score — A newer (2024) compounding desk whose real hook is form: it runs an oral/sublingual line alongside the usual injections, on both molecules, with no membership tacked on.
That doesn't make Try Ageless a bad call — it's best for readers who want a choice of injection or sublingual drops from a desk that will name the pharmacy and the prescriber — and who will read past the hero to the month-to-month column. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Try Ageless | Direct Meds | |
|---|---|---|
| Brief Score | 58/100 (C) | 82/100 (B−) |
| Semaglutide | $279/mo month-to-month, compounded injection — the "from $199" beside it is the 12-month rung, billed as $2,388 up front | $249/mo sublingual · $297/mo injectable |
| Tirzepatide | $349/mo month-to-month, compounded injection; sublingual drops $199/mo — the "from $249" and "from $159" on the same page are 12-month rungs ($2,988 and $1,908 up front) | $299/mo sublingual · $399/mo injectable |
| Coverage | Coverage not published anywhere on the site | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
Try Ageless: First reading, 8 August 2026. Month-to-month is $279 semaglutide injection, $349 tirzepatide injection and $199 tirzepatide sublingual drops. The "$159/mo from" in the hero and the "FROM $199 / $249" entry cards are all twelve-month rungs, charged as $1,908, $2,388 and $2,988 in a single payment. Separately, Try Ageless's own public shop lists the same semaglutide injection at $119–229 depending on prescribed dose as a one-time purchase — a cheaper path the link we publish does not lead to.
Direct Meds: Company-stated rates unchanged this cycle — but we price these off the desk's own listings, not a live-verified checkout, so treat them as indicative.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.